TECENTRIQ Presentation
Loading Map....
TECENTRIQ: First FDA–Approved Adjuvant Cancer Immunotherapy for Stage II to III APD-L1+NSCLC
FEATURED FACULTY
Eric Nadler, MD
Baylor University Medical Center
Dallas, TX
RSVP:
Angie Horn Redmann at (650) 580-8821